申请人:GENENTECH, INC.
公开号:US10071957B2
公开(公告)日:2018-09-11
The invention provides novel compounds having the general formula (I) and pharmaceutically acceptable salts thereof, wherein the variables RA, subscript n, ring A, X2, L, subscript m, X1, ring D, R1, and RN have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.
本发明提供了具有通式 (I) 的新型化合物及其药学上可接受的盐类,其中变量 RA、下标 n、环 A、X2、L、下标 m、X1、环 D、R1 和 RN 的含义如本文所述,本发明还提供了含有此类化合物的组合物以及使用此类化合物和组合物的方法。